SIMILAR PATTERNS OF AMINO ACIDS FOR 3LS4_H_TCIH220_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1abr ABRIN-A

(Abrus
precatorius) 		PF00161
(RIP) 		4 TYR A  17
ILE A  64
LEU A  56
PHE A   7
 None
 1.27A 3ls4L-1abrA:
undetectable		 3ls4L-1abrA:
23.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ap2 MONOCLONAL ANTIBODY
C219

(Mus musculus) 		PF07686
(V-set) 		4 TYR A  42
GLN A  95
LEU A 102
PHE A 104
 None
 0.55A 3ls4L-1ap2A:
20.4		 3ls4L-1ap2A:
51.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cb8 PROTEIN
(CHONDROITINASE AC)

(Pedobacter
heparinus) 		PF02278
(Lyase_8)
PF02884
(Lyase_8_C)
PF08124
(Lyase_8_N) 		4 TYR A 348
GLN A 350
ILE A 336
LEU A 352
 None
 1.25A 3ls4L-1cb8A:
undetectable		 3ls4L-1cb8A:
16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dkp PHYTASE

(Escherichia
coli) 		PF00328
(His_Phos_2) 		4 GLN A 258
ILE A 144
LEU A 257
PHE A 254
 None
None
None
IHP  A 550 (-4.4A)
 1.16A 3ls4L-1dkpA:
undetectable		 3ls4L-1dkpA:
18.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1h8s MUTANT AL2 6E7P9G

(Mus musculus) 		PF07686
(V-set) 		4 TYR A  39
GLN A  92
LEU A  99
PHE A 101
 None
AIC  A1000 (-3.3A)
AIC  A1000 (-4.5A)
None
 0.50A 3ls4L-1h8sA:
21.0		 3ls4L-1h8sA:
39.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hk7 HEAT SHOCK PROTEIN
HSP82

(Saccharomyces
cerevisiae) 		PF00183
(HSP90) 		4 TYR A 289
ILE A 396
LEU A 321
PHE A 322
 None
 1.13A 3ls4L-1hk7A:
undetectable		 3ls4L-1hk7A:
20.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1i3g ANTIBODY FV FRAGMENT

(Mus musculus) 		PF07686
(V-set) 		4 TYR L  44
GLN L 107
LEU L 137
PHE L 139
 None
MPD  L 500 (-3.1A)
None
None
 0.52A 3ls4L-1i3gL:
21.4		 3ls4L-1i3gL:
59.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kwc 2,3-DIHYDROXYBIPHENY
L DIOXYGENASE

(Pseudomonas sp.
KKS102) 		PF00903
(Glyoxalase) 		4 TYR B 160
ILE B 143
LEU B   5
PHE B 166
 None
 1.00A 3ls4L-1kwcB:
undetectable		 3ls4L-1kwcB:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1lk3 9D7 LIGHT CHAIN

(Rattus
norvegicus) 		PF07654
(C1-set)
PF07686
(V-set) 		4 TYR L  35
GLN L  88
LEU L  95
PHE L  97
 None
 0.36A 3ls4L-1lk3L:
26.9		 3ls4L-1lk3L:
74.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nio B-LUFFIN

(Luffa
aegyptiaca) 		PF00161
(RIP) 		4 TYR A  15
ILE A  61
LEU A  53
PHE A   5
 None
 1.28A 3ls4L-1nioA:
undetectable		 3ls4L-1nioA:
22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pn3 GLYCOSYLTRANSFERASE
GTFA

(Amycolatopsis
orientalis) 		PF03033
(Glyco_transf_28) 		4 TYR A 225
ILE A 202
LEU A 301
PHE A 284
 None
None
TYD  A 406 (-4.6A)
None
 1.16A 3ls4L-1pn3A:
undetectable		 3ls4L-1pn3A:
18.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qdu CASPASE-8
ALPHA-CHAIN

(Homo sapiens) 		PF00656
(Peptidase_C14) 		4 GLN A 264
ILE A 243
LEU A 261
PHE A 265
 None
 1.19A 3ls4L-1qduA:
undetectable		 3ls4L-1qduA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qdu CASPASE-8
ALPHA-CHAIN

(Homo sapiens) 		PF00656
(Peptidase_C14) 		4 GLN A 264
ILE A 258
LEU A 261
PHE A 265
 None
 0.97A 3ls4L-1qduA:
undetectable		 3ls4L-1qduA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rh9 ENDO-BETA-MANNANASE

(Solanum
lycopersicum) 		PF00150
(Cellulase) 		4 TYR A 341
ILE A 128
LEU A 358
PHE A 319
 None
 1.28A 3ls4L-1rh9A:
undetectable		 3ls4L-1rh9A:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1thg LIPASE 2

(Galactomyces
candidus) 		PF00135
(COesterase) 		4 TYR A 146
GLN A 470
LEU A 467
PHE A 471
 None
 1.23A 3ls4L-1thgA:
undetectable		 3ls4L-1thgA:
18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u71 DIHYDROFOLATE
REDUCTASE

(Homo sapiens) 		PF00186
(DHFR_1) 		4 TYR A 177
GLN A 170
LEU A 166
PHE A 179
 None
 1.20A 3ls4L-1u71A:
undetectable		 3ls4L-1u71A:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1usv HEAT SHOCK PROTEIN
HSP82

(Saccharomyces
cerevisiae) 		PF00183
(HSP90) 		4 TYR A 289
ILE A 396
LEU A 321
PHE A 322
 None
 1.21A 3ls4L-1usvA:
undetectable		 3ls4L-1usvA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yxa SERINE (OR CYSTEINE)
PROTEINASE
INHIBITOR, CLADE A,
MEMBER 3N

(Mus musculus) 		PF00079
(Serpin) 		4 TYR A 181
ILE A 344
LEU A 139
PHE A 140
 None
 1.27A 3ls4L-1yxaA:
undetectable		 3ls4L-1yxaA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zbm HYPOTHETICAL PROTEIN
AF1704

(Archaeoglobus
fulgidus) 		PF02621
(VitK2_biosynth) 		4 TYR A 232
GLN A 146
ILE A 128
PHE A 228
 None
 1.23A 3ls4L-1zbmA:
undetectable		 3ls4L-1zbmA:
19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2abj BRANCHED-CHAIN-AMINO
-ACID
AMINOTRANSFERASE,
CYTOSOLIC

(Homo sapiens) 		PF01063
(Aminotran_4) 		4 TYR A 372
GLN A 371
ILE A 292
LEU A 367
 None
 1.23A 3ls4L-2abjA:
undetectable		 3ls4L-2abjA:
21.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ap2 SINGLE CHAIN FV

(Mus musculus) 		PF07686
(V-set) 		4 TYR A  42
GLN A  95
LEU A 102
PHE A 104
 None
 0.45A 3ls4L-2ap2A:
20.3		 3ls4L-2ap2A:
57.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bde CYTOSOLIC IMP-GMP
SPECIFIC
5'-NUCLEOTIDASE

(Legionella
pneumophila) 		PF05761
(5_nucleotid) 		4 TYR A 402
GLN A 398
ILE A 391
LEU A 395
 None
 1.14A 3ls4L-2bdeA:
undetectable		 3ls4L-2bdeA:
17.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2blb DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE

(Plasmodium
vivax) 		PF00186
(DHFR_1) 		4 TYR A  79
ILE A 155
LEU A 159
PHE A   8
 None
 1.27A 3ls4L-2blbA:
undetectable		 3ls4L-2blbA:
21.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2c1o IGK-C PROTEIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		4 TYR A 173
GLN A 166
ILE A  15
LEU A 106
 None
 1.16A 3ls4L-2c1oA:
25.5		 3ls4L-2c1oA:
67.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cg9 ATP-DEPENDENT
MOLECULAR CHAPERONE
HSP82

(Saccharomyces
cerevisiae) 		PF00183
(HSP90)
PF02518
(HATPase_c) 		4 TYR A 289
ILE A 396
LEU A 321
PHE A 322
 None
 1.24A 3ls4L-2cg9A:
undetectable		 3ls4L-2cg9A:
15.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dh4 YPL069C

(Saccharomyces
cerevisiae) 		PF00348
(polyprenyl_synt) 		4 TYR A 292
GLN A 164
LEU A 168
PHE A 241
 None
 1.16A 3ls4L-2dh4A:
undetectable		 3ls4L-2dh4A:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g5d GNA33

(Neisseria
gonorrhoeae) 		PF03562
(MltA)
PF06725
(3D) 		4 TYR A  61
GLN A 429
ILE A 389
LEU A 372
 None
 1.17A 3ls4L-2g5dA:
undetectable		 3ls4L-2g5dA:
16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gpi CONSERVED
HYPOTHETICAL PROTEIN

(Shewanella
loihica) 		PF07369
(DUF1488) 		4 GLN A  60
ILE A  48
LEU A  57
PHE A  61
 None
 1.21A 3ls4L-2gpiA:
undetectable		 3ls4L-2gpiA:
17.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hpi DNA POLYMERASE III
ALPHA SUBUNIT

(Thermus
aquaticus) 		PF02811
(PHP)
PF07733
(DNA_pol3_alpha)
PF14579
(HHH_6) 		4 GLN A 603
ILE A  69
LEU A  50
PHE A  51
 None
 1.26A 3ls4L-2hpiA:
undetectable		 3ls4L-2hpiA:
10.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o2t MULTIPLE PDZ DOMAIN
PROTEIN

(Homo sapiens) 		PF00595
(PDZ) 		4 TYR A 228
GLN A 187
ILE A 191
PHE A 166
 None
 1.21A 3ls4L-2o2tA:
undetectable		 3ls4L-2o2tA:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p0u STILBENECARBOXYLATE
SYNTHASE 2

(Marchantia
polymorpha) 		PF00195
(Chal_sti_synt_N)
PF02797
(Chal_sti_synt_C) 		4 TYR A  54
ILE A 115
LEU A  90
PHE A  88
 None
 1.23A 3ls4L-2p0uA:
undetectable		 3ls4L-2p0uA:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p9w MAL S 1 ALLERGENIC
PROTEIN

(Malassezia
sympodialis) 		no annotation 4 TYR A 313
GLN A 318
ILE A 347
LEU A 320
 None
 1.12A 3ls4L-2p9wA:
undetectable		 3ls4L-2p9wA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2phl PHASEOLIN

(Phaseolus
vulgaris) 		PF00190
(Cupin_1) 		4 GLN A  68
ILE A 192
LEU A  65
PHE A 118
 None
 1.11A 3ls4L-2phlA:
2.1		 3ls4L-2phlA:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r15 MYOMESIN-1

(Homo sapiens) 		PF07679
(I-set) 		4 TYR A1555
GLN A1559
ILE A1566
PHE A1558
 None
 1.17A 3ls4L-2r15A:
11.0		 3ls4L-2r15A:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn7 GLUCOAMYLASE

(Trichoderma
reesei) 		PF00686
(CBM_20)
PF00723
(Glyco_hydro_15) 		4 TYR A  70
GLN A  75
ILE A 155
PHE A  66
 None
 1.22A 3ls4L-2vn7A:
2.9		 3ls4L-2vn7A:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yky BETA-TRANSAMINASE

(Mesorhizobium
sp. LUK) 		PF00202
(Aminotran_3) 		4 TYR A 415
ILE A 437
LEU A 433
PHE A 429
 None
 1.19A 3ls4L-2ykyA:
undetectable		 3ls4L-2ykyA:
17.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zr1 AGGLUTININ-1 CHAIN A

(Abrus
precatorius) 		PF00161
(RIP) 		4 TYR A  16
ILE A  63
LEU A  55
PHE A   6
 None
 1.27A 3ls4L-2zr1A:
undetectable		 3ls4L-2zr1A:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3anv D-SERINE DEHYDRATASE

(Gallus gallus) 		PF01168
(Ala_racemase_N)
PF14031
(D-ser_dehydrat) 		4 TYR A 346
GLN A 249
ILE A 189
LEU A 253
 None
 1.13A 3ls4L-3anvA:
undetectable		 3ls4L-3anvA:
17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3awk CHALCONE
SYNTHASE-LIKE
POLYKETIDE SYNTHASE

(Huperzia
serrata) 		PF00195
(Chal_sti_synt_N)
PF02797
(Chal_sti_synt_C) 		4 TYR A  46
ILE A 107
LEU A  82
PHE A  80
 None
 1.22A 3ls4L-3awkA:
undetectable		 3ls4L-3awkA:
20.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3cvh 25-D1.16 LIGHT CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		4 TYR L  35
GLN L  88
LEU L  95
PHE L  97
 None
 0.45A 3ls4L-3cvhL:
26.3		 3ls4L-3cvhL:
79.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d46 PUTATIVE GALACTONATE
DEHYDRATASE

(Salmonella
enterica) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		4 TYR A  32
GLN A 363
ILE A 379
PHE A 364
 None
 1.08A 3ls4L-3d46A:
undetectable		 3ls4L-3d46A:
18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ehm SUSD HOMOLOG

(Bacteroides
thetaiotaomicron) 		PF12741
(SusD-like) 		4 TYR A 366
GLN A 438
ILE A 274
LEU A 441
 None
 1.24A 3ls4L-3ehmA:
undetectable		 3ls4L-3ehmA:
17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ejn SUSD HOMOLOG

(Bacteroides
fragilis) 		PF12771
(SusD-like_2) 		4 TYR A 336
GLN A 340
ILE A 352
LEU A 343
 None
 1.22A 3ls4L-3ejnA:
undetectable		 3ls4L-3ejnA:
18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fd3 CHROMOSOME
REPLICATION
INITIATION INHIBITOR
PROTEIN

(Agrobacterium
fabrum) 		PF03466
(LysR_substrate) 		4 TYR A 237
GLN A 223
ILE A 286
LEU A 222
 None
None
None
EDO  A 322 (-4.4A)
 1.06A 3ls4L-3fd3A:
undetectable		 3ls4L-3fd3A:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gd9 LAMINARIPENTAOSE-PRO
DUCING
BETA-1,3-GULUASE
(LPHASE)

(Streptomyces
matensis) 		PF16483
(Glyco_hydro_64) 		4 TYR A 247
ILE A 321
LEU A 325
PHE A 329
 None
 1.20A 3ls4L-3gd9A:
undetectable		 3ls4L-3gd9A:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gvy BACTERIOFERRITIN

(Rhodobacter
sphaeroides) 		PF00210
(Ferritin) 		4 TYR A 133
GLN A 137
ILE A 144
LEU A 140
 None
 1.02A 3ls4L-3gvyA:
undetectable		 3ls4L-3gvyA:
18.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3j8v H16.14J LIGHT CHAIN

(Mus musculus) 		no annotation 4 TYR L  36
GLN L  89
LEU L  96
PHE L  98
 None
 0.50A 3ls4L-3j8vL:
21.0		 3ls4L-3j8vL:
61.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o0r ANTIBODY FAB
FRAGMENT LIGHT CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		4 TYR L  36
GLN L  89
LEU L  96
PHE L  98
 None
 0.53A 3ls4L-3o0rL:
27.1		 3ls4L-3o0rL:
82.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pry HEAT SHOCK PROTEIN
HSP 90-BETA

(Homo sapiens) 		PF00183
(HSP90) 		4 TYR A 301
ILE A 408
LEU A 333
PHE A 334
 None
 1.08A 3ls4L-3pryA:
undetectable		 3ls4L-3pryA:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q48 CHAPERONE CUPB2

(Pseudomonas
aeruginosa) 		PF00345
(PapD_N)
PF02753
(PapD_C) 		4 TYR A 184
ILE A  99
LEU A 142
PHE A 143
 None
 1.25A 3ls4L-3q48A:
5.5		 3ls4L-3q48A:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r5t FERRIC VIBRIOBACTIN
ABC TRANSPORTER,
PERIPLASMIC FERRIC
VIBRIOBACTIN-BINDING
PROTEIN

(Vibrio cholerae) 		PF01497
(Peripla_BP_2) 		4 GLN A 157
ILE A  68
LEU A 158
PHE A  37
 MOH  A   3 ( 2.6A)
None
None
EDO  A   4 (-4.0A)
 1.21A 3ls4L-3r5tA:
undetectable		 3ls4L-3r5tA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t1e HEMAGGLUTININ-NEURAM
INIDASE

(Avian
avulavirus 1) 		PF00423
(HN) 		4 TYR A 132
ILE A 544
LEU A 542
PHE A 531
 None
 1.23A 3ls4L-3t1eA:
undetectable		 3ls4L-3t1eA:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zhc PHYTASE

(Citrobacter
braakii) 		PF00328
(His_Phos_2) 		4 GLN A 257
ILE A 144
LEU A 256
PHE A 253
 None
 1.26A 3ls4L-3zhcA:
undetectable		 3ls4L-3zhcA:
18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zuc CELLULOSOMAL
SCAFFOLDIN

(Acetivibrio
cellulolyticus) 		PF00942
(CBM_3) 		4 TYR A 118
ILE A  89
LEU A  87
PHE A  47
 None
 1.15A 3ls4L-3zucA:
undetectable		 3ls4L-3zucA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ccy CARBOXYLESTERASE
YBFK

(Bacillus
subtilis) 		PF12697
(Abhydrolase_6) 		4 TYR B  22
GLN B 200
ILE B 183
PHE B  18
 None
 1.27A 3ls4L-4ccyB:
undetectable		 3ls4L-4ccyB:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4djm DRAB

(Escherichia
coli) 		PF00345
(PapD_N)
PF02753
(PapD_C) 		4 TYR A 181
ILE A  88
LEU A 145
PHE A 146
 None
 1.24A 3ls4L-4djmA:
2.8		 3ls4L-4djmA:
23.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dqd EXTRACELLULAR
LIGAND-BINDING
RECEPTOR

(Rhodopseudomonas
palustris) 		PF13458
(Peripla_BP_6) 		4 TYR A 292
ILE A  91
LEU A 308
PHE A 288
 None
 1.26A 3ls4L-4dqdA:
undetectable		 3ls4L-4dqdA:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fzh HEMAGGLUTININ-NEURAM
INIDASE

(Avian
avulavirus 1) 		PF00423
(HN) 		4 TYR A 132
ILE A 545
LEU A 543
PHE A 532
 None
 1.17A 3ls4L-4fzhA:
undetectable		 3ls4L-4fzhA:
17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gbm CURM
SULFOTRANSFERASE

(Moorea
producens) 		PF13469
(Sulfotransfer_3) 		4 TYR A 137
ILE A 125
LEU A 130
PHE A  33
 CL  A 412 (-4.6A)
None
None
None
 1.04A 3ls4L-4gbmA:
undetectable		 3ls4L-4gbmA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gkl ALPHA-AMYLASE

(Thermotoga
neapolitana) 		PF00128
(Alpha-amylase) 		4 TYR A 243
GLN A 239
ILE A 233
LEU A 236
 None
 1.25A 3ls4L-4gklA:
undetectable		 3ls4L-4gklA:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ij2 IRON-REGULATED
SURFACE DETERMINANT
PROTEIN H

(Staphylococcus
aureus) 		PF05031
(NEAT) 		4 TYR E 484
GLN E 493
ILE E 598
LEU E 490
 None
 1.25A 3ls4L-4ij2E:
4.0		 3ls4L-4ij2E:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kk2 MONOTERPENE SYNTHASE
FDS-5, CHLOROPLASTIC
- FARNESYL
DIPHOSPHATE SYNTHASE
1 CHIMERA

(Artemisia
spiciformis) 		PF00348
(polyprenyl_synt) 		4 TYR A 231
GLN A 235
ILE A 248
LEU A 239
 None
 1.11A 3ls4L-4kk2A:
undetectable		 3ls4L-4kk2A:
19.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4llu LIGHT CHAIN CLAMBDA

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		4 TYR B  36
GLN B  89
ILE B  93
PHE B  98
 None
 1.27A 3ls4L-4lluB:
23.9		 3ls4L-4lluB:
49.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lm8 EXTRACELLULAR IRON
OXIDE RESPIRATORY
SYSTEM SURFACE
DECAHEME CYTOCHROME
C COMPONENT MTRC

(Shewanella
oneidensis) 		PF14522
(Cytochrome_C7) 		4 TYR A  58
GLN A 141
ILE A  92
LEU A 139
 None
 1.27A 3ls4L-4lm8A:
2.6		 3ls4L-4lm8A:
16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mwz PHOSPHOETHANOLAMINE
N-METHYLTRANSFERASE,
PUTATIVE

(Plasmodium
vivax) 		PF13649
(Methyltransf_25) 		4 TYR A 172
GLN A 253
ILE A 183
PHE A 169
 PO4  A 302 (-4.5A)
None
None
None
 1.27A 3ls4L-4mwzA:
undetectable		 3ls4L-4mwzA:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q5w MATERNAL PROTEIN
TUDOR

(Drosophila
melanogaster) 		PF00567
(TUDOR) 		4 TYR A2071
GLN A2033
LEU A2038
PHE A2040
 None
 1.19A 3ls4L-4q5wA:
undetectable		 3ls4L-4q5wA:
23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qdv M7GPPPX
DIPHOSPHATASE

(Homo sapiens) 		PF05652
(DcpS)
PF11969
(DcpS_C) 		4 GLN A 249
ILE A 302
LEU A 245
PHE A 280
 None
 1.25A 3ls4L-4qdvA:
undetectable		 3ls4L-4qdvA:
17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uwm 3,6-DIKETOCAMPHANE
1,6 MONOOXYGENASE

(Pseudomonas
putida) 		PF00296
(Bac_luciferase) 		4 GLN A  32
ILE A 365
LEU A 362
PHE A 359
 None
 1.23A 3ls4L-4uwmA:
undetectable		 3ls4L-4uwmA:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wht LIGHT CHAIN OF THE
FAB FRAGMENT DERIVED
FROM NEUTRALIZING
ANTIBODY 3/11

(Rattus
norvegicus) 		no annotation 4 TYR J 177
GLN J 170
ILE J  15
LEU J 110
 None
 1.26A 3ls4L-4whtJ:
26.8		 3ls4L-4whtJ:
68.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wzs SIMILARITY TO
HELICASE MOT1

(Encephalitozoon
cuniculi) 		no annotation 4 GLN C  70
ILE C  63
LEU C  67
PHE C  71
 None
 1.17A 3ls4L-4wzsC:
undetectable		 3ls4L-4wzsC:
14.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x7m TARM

(Staphylococcus
aureus) 		PF00534
(Glycos_transf_1) 		4 TYR A 402
GLN A 401
ILE A 446
LEU A 335
 None
 1.21A 3ls4L-4x7mA:
undetectable		 3ls4L-4x7mA:
17.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z6y TBC1 DOMAIN FAMILY
MEMBER 7

(Homo sapiens) 		no annotation 4 TYR B 166
GLN B 161
ILE B  66
LEU B  64
 None
 1.10A 3ls4L-4z6yB:
undetectable		 3ls4L-4z6yB:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5aa5 NIFE-HYDROGENASE
LARGE SUBUNIT, HOFG
NIFE-HYDROGENASE
SMALL SUBUNIT, HOFK

(Cupriavidus
necator) 		PF00374
(NiFeSe_Hases)
PF01058
(Oxidored_q6)
PF14720
(NiFe_hyd_SSU_C) 		4 TYR C 183
ILE A  23
LEU A  63
PHE C 178
 None
 1.18A 3ls4L-5aa5C:
undetectable		 3ls4L-5aa5C:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b3n ANTI-H4K20ME1_SCFV

(Mus musculus) 		PF07686
(V-set) 		4 TYR A 178
GLN A 231
LEU A 238
PHE A 240
 None
 0.28A 3ls4L-5b3nA:
21.2		 3ls4L-5b3nA:
63.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b8c PEMBROLIZUMAB LIGHT
CHAIN VARIABLE
REGION (PEMVL)

(Homo sapiens) 		PF07686
(V-set) 		4 TYR A  40
GLN A  93
LEU A 100
PHE A 102
 None
 0.33A 3ls4L-5b8cA:
21.2		 3ls4L-5b8cA:
35.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5cma ANTIBODY CH8H9 FAB
LIGHT CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		4 TYR A  36
GLN A  89
LEU A  96
PHE A  98
 None
 0.46A 3ls4L-5cmaA:
26.4		 3ls4L-5cmaA:
60.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5efr BAMA-BAMD FUSION
PROTEIN

(Rhodothermus
marinus) 		PF07244
(POTRA)
PF13525
(YfiO) 		4 TYR A1101
GLN A1074
ILE A1054
LEU A1077
 None
 1.06A 3ls4L-5efrA:
undetectable		 3ls4L-5efrA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fcd MCCD

(Escherichia
coli) 		PF13649
(Methyltransf_25) 		4 TYR A 158
GLN A 253
ILE A 246
LEU A 250
 None
 1.06A 3ls4L-5fcdA:
undetectable		 3ls4L-5fcdA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gsm EXO-BETA-D-GLUCOSAMI
NIDASE

(Thermococcus
kodakarensis) 		PF02449
(Glyco_hydro_42) 		4 TYR A 327
GLN A 284
ILE A 186
LEU A 283
 None
 0.97A 3ls4L-5gsmA:
undetectable		 3ls4L-5gsmA:
13.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h2v IMPORTIN SUBUNIT
BETA-3

(Saccharomyces
cerevisiae) 		PF13513
(HEAT_EZ) 		4 TYR A 819
ILE A 178
LEU A 216
PHE A 205
 None
 1.20A 3ls4L-5h2vA:
undetectable		 3ls4L-5h2vA:
11.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h7c IMMUNOGLOBULIN
G-BINDING PROTEIN A,
DHR14

(Staphylococcus
aureus;
synthetic
construct) 		PF02216
(B) 		4 TYR A 210
GLN A 206
ILE A 199
LEU A 203
 None
 1.09A 3ls4L-5h7cA:
undetectable		 3ls4L-5h7cA:
20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lx8 SUSD HOMOLOG

(Bacteroides
thetaiotaomicron) 		PF07980
(SusD_RagB)
PF14322
(SusD-like_3) 		4 TYR A 228
GLN A 157
ILE A 108
LEU A 158
 None
 1.06A 3ls4L-5lx8A:
undetectable		 3ls4L-5lx8A:
16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nno ALDEHYDE
DEHYDROGENASE

(Trypanosoma
brucei) 		PF00171
(Aldedh) 		4 TYR A 444
GLN A 136
ILE A  77
LEU A  80
 None
 1.08A 3ls4L-5nnoA:
undetectable		 3ls4L-5nnoA:
16.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5tr1 MONOCLONAL ANTIBODY,
FAB FRAGMENT, LIGHT
CHAIN

(Mus musculus) 		PF07686
(V-set) 		4 TYR L  36
GLN L  89
LEU L  96
PHE L  98
 None
 0.62A 3ls4L-5tr1L:
20.8		 3ls4L-5tr1L:
58.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u1s SEPARIN

(Saccharomyces
cerevisiae) 		PF03568
(Peptidase_C50) 		4 TYR A1539
GLN A 882
ILE A 888
LEU A 885
 None
 1.09A 3ls4L-5u1sA:
undetectable		 3ls4L-5u1sA:
9.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5u3k DH511.2 FAB LIGHT
CHAIN

(Homo sapiens) 		no annotation 4 TYR L  36
GLN L  89
LEU L  96
PHE L  98
 None
 0.94A 3ls4L-5u3kL:
25.8		 3ls4L-5u3kL:
58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5u3p DH511.4 FAB LIGHT
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		4 TYR L  36
GLN L  89
LEU L  96
PHE L  98
 None
 0.87A 3ls4L-5u3pL:
20.5		 3ls4L-5u3pL:
56.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x6x MRNA CAPPING ENZYME
P5

(Rice dwarf
virus) 		no annotation 4 TYR C 603
GLN C 561
ILE C 788
LEU C 791
 None
 1.19A 3ls4L-5x6xC:
undetectable		 3ls4L-5x6xC:
20.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5xcu VL-SARAH(S37C)
CHIMERA,VL-SARAH(S37
C) CHIMERA

(Homo sapiens;
Mus musculus) 		PF07686
(V-set)
PF11629
(Mst1_SARAH) 		4 TYR B  36
GLN B  89
LEU B  96
PHE B  98
 None
 0.39A 3ls4L-5xcuB:
20.3		 3ls4L-5xcuB:
38.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5xcx VL-SARAH(S37C)
CHIMERA

(Homo sapiens;
Mus musculus) 		PF07686
(V-set)
PF11629
(Mst1_SARAH) 		5 TYR B  36
GLN B  89
ILE B  94
LEU B  96
PHE B  98
 None
None
CXS  A 204 ( 4.9A)
None
None
 0.31A 3ls4L-5xcxB:
23.2		 3ls4L-5xcxB:
50.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zc3 -

(-) 		no annotation 4 GLN B 140
ILE B 133
LEU B 137
PHE B 141
 None
 1.27A 3ls4L-5zc3B:
undetectable		 3ls4L-5zc3B:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6aq7 POM6 FAB LIGHT CHAIN

(Mus musculus) 		no annotation 4 TYR L  40
GLN L  93
LEU L 100
PHE L 102
 None
 1.03A 3ls4L-6aq7L:
26.6		 3ls4L-6aq7L:
25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bsp U4 LIGHT CHAIN

(Mus musculus) 		no annotation 4 TYR B  36
GLN B  89
LEU B  96
PHE B  98
 None
 1.27A 3ls4L-6bspB:
12.3		 3ls4L-6bspB:
27.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6byo VOLTAGE-DEPENDENT
L-TYPE CALCIUM
CHANNEL SUBUNIT
ALPHA-1S

(Oryctolagus
cuniculus) 		no annotation 4 TYR A 627
ILE A 572
LEU A 576
PHE A 581
 None
 1.22A 3ls4L-6byoA:
undetectable		 3ls4L-6byoA:
18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c6l V-TYPE PROTON ATPASE
SUBUNIT A, VACUOLAR
ISOFORM

(Saccharomyces
cerevisiae) 		no annotation 4 TYR A 550
ILE A   8
LEU A 409
PHE A 554
 None
 1.26A 3ls4L-6c6lA:
undetectable		 3ls4L-6c6lA:
21.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6ehx SCFV ABVANCE:
INCREASING OUR
KNOWLEDGE OF
ANTIBODY STRUCTURAL
SPACE TO ENABLE
FASTER AND BETTER
DECISION MAKING IN
DRUG DISCOVERY

(Homo sapiens) 		no annotation 4 TYR B 172
GLN B 225
LEU B 232
PHE B 234
 None
 0.40A 3ls4L-6ehxB:
22.3		 3ls4L-6ehxB:
68.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6ehy SCFV ANTIBODY
FRAGMENT

(Homo sapiens) 		no annotation 4 TYR A 174
GLN A 227
LEU A 234
PHE A 236
 None
 0.41A 3ls4L-6ehyA:
21.7		 3ls4L-6ehyA:
36.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ez8 FACTOR VIII INTRON
22 PROTEIN
HUNTINGTIN

(Homo sapiens) 		no annotation 4 GLN A2272
ILE B 364
LEU A2269
PHE A2383
 None
 1.15A 3ls4L-6ez8A:
undetectable		 3ls4L-6ez8A:
11.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fb3 TENEURIN-2

(Gallus gallus) 		no annotation 4 TYR A2105
GLN A2103
ILE A2128
PHE A2117
 None
 1.27A 3ls4L-6fb3A:
undetectable		 3ls4L-6fb3A:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gdt -

(-) 		no annotation 4 TYR A 454
GLN A 562
ILE A  90
PHE A 566
 None
 1.03A 3ls4L-6gdtA:
6.3		 3ls4L-6gdtA:
undetectable